Journal of Clinical Epigenetics Open Access

  • ISSN: 2472-1158
  • Journal h-index: 10
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Articles published in Journal of Clinical Epigenetics have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Epigenetics has got h-index 10, which means every article in Journal of Clinical Epigenetics has got 10 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Epigenetics.

  2021 2020 2019 2018 2017

Year wise published articles

42 27 3 14 51

Year wise citations received

87 80 75 84 61
Journal total citations count 474
Journal h-index 10
Journal h-index since 2016 10
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
Wang G, Bieberich E (2017)  Morphogenetic Sphingolipids in Stem Cell Differentiation and Embryo Development. In Lipidomics of Stem Cells  Springer International Publishing 2: 11-40
de Vries NL, Swets M, Vahrmeijer AL, Hokland M, Kuppen PJ (2016) The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment. International Journal of Molecular Sciences.  17: 1030.
Stuckey JI (2016) Design and characterization of chemical probes targeting the chromodomains of Polycomb Repressive Complex I (Doctoral dissertation, The University of North Carolina at Chapel Hill).
Singh J, Sharma D, Bansal R (2017) Pyridazinone: an attractive lead for anti-inflammatory and analgesic drug discovery. Future Medicinal Chemistry 9: 95-127.
Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K (2016) Epigenetic Treatment of Persistent Viral Infections. Drug Development Research.
Damaskos C, Valsami S, Spartalis E, Antoniou EA, Tomos P, et al. (2016)  Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?. Anticancer Research 36: 5019-5024.
de Lera AR, Ganesan A (2016) Epigenetic polypharmacology: from combination therapy to multitargeted drugs. Clin epig 8: 105.
Berezin AE (2016) Different Obese Phenotypes and Progenitor Endothelial Cell Dysfunction: The Missed Link to Cardiovascular Risk. Ann Clin Lab Res.
Berezin AE (2016) Different Obese Phenotypes and Progenitor Endothelial Cell Dysfunction: The Missed Link to Cardiovascular Risk. Ann Clin Lab Res 4: 4.
Berezin AE (2016)  The Heart Failure Risk Predictive Scores Based on the Genetic Features: Hope and Hype.
Berezin AE (2017) The Role of Vistafin in Diabetes-Induced Impairment of Endothelial Repair System. Transl Biomed 8: 1.
Berezin AE (2016) Endothelial progenitor cells dysfunction and impaired tissue reparation: The missed link in diabetes mellitus development. Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
Berezin AE (2016)  Epigenetic Mechanisms of Endothelial Progenitor Cell Dysfunction. J ClinEpig.
Chaâbane M, Ghorbel I, Elwej A, Mnif H, Boudawara T (2016) Penconazole alters redox status, cholinergic function, and membrane-bound ATPases in the cerebrum and cerebellum of adult rats. Human & Experimental Toxicology.
Hassani S, Momtaz S, Vakhshiteh F, Maghsoudi AS, Ganjali MR, et al. (2016) Biosensors and their applications in detection of organophosphorus pesticides in the environment. Arch  Toxicol 19: 1-22.